Frost & Sullivan

MARCH 30, 2021

Pharmaceuticals and biotechnology, IVD, advanced medical technologies, medical imaging and informatics, and digital health expected to hit over $2.6 Between 2021 and 2023, innovative business models are expected to emerge. trillion by 2025. Santa Clara, Calif. trillion by 2025, growing at a compound annual growth rate of 6.3%.

Biotechnology 98

Biotechnology Life science Government Biopharmaceuticals 98

Frost & Sullivan

AUGUST 6, 2023

San Antonio, TX — 7 th Aug, 2023 — Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.

Biotechnology 52

Biotechnology Biotech Contract research organization Biopharmaceuticals 52

Frost & Sullivan

APRIL 25, 2023

April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

Frost & Sullivan

MARCH 30, 2021

Pharmaceuticals and biotechnology, IVD, advanced medical technologies, medical imaging and informatics, and digital health expected to hit over $2.6 Between 2021 and 2023, innovative business models are expected to emerge. trillion by 2025. Santa Clara, Calif. trillion by 2025, growing at a compound annual growth rate of 6.3%.

Biotechnology 52

Biotechnology Life science Government Biopharmaceuticals 52